Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy
Hongying Sui, Caixia Shi, Zhipeng Yan, Hucheng LiDepartment of Gynecological Oncology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha City, People’s Republic of ChinaBackground: Ovarian cancer is the leading cause of...
Saved in:
Main Authors: | Sui H (Author), Shi C (Author), Yan Z (Author), Li H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-tumour and radiosensitising effects of PARP inhibitor on cervical cancer xenografts
by: Qin Xue, et al.
Published: (2023) -
Glycyrrhetinic Acid Inhibits Cell Growth and Induces Apoptosis in Ovarian Cancer A2780 Cells
by: Venus Haghshenas, et al.
Published: (2014) -
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
by: Ekaterina V Blinova, et al.
Published: (2018) -
Cajanol Sensitizes A2780/Taxol Cells to Paclitaxel by Inhibiting the PI3K/Akt/NF-κB Signaling Pathway
by: Ming Sui, et al.
Published: (2021) -
Increase in serum creatinine levels after PARP inhibitor treatment
by: Di You, et al.
Published: (2023)